Physician profile
Bryan Boyle
NPI 1588205744
$1,041.20
in general payments reported to CMS, 2019-2025
13 companies · $83.15 in 2025
The $83.15 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $320 · 2022: $214 · 2023: $329 · 2024: $95.20 · 2025: $83.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $262.32 | 2021-2024 | |
| Amgen INC. | $156.01 | 2021-2025 | Repatha, Otezla, Repatha |
| Janssen Pharmaceuticals, INC | $154.87 | 2023-2024 | Spravato, Invega Sustenna |
| Glaxosmithkline, LLC. | $125.00 | 2022 | |
| Indivior INC. | $108.92 | 2023-2025 | Sublocade, Perseris |
| Novo Nordisk INC | $79.20 | 2023 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $54.24 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $33.97 | 2021-2024 | |
| Dexcom, INC. | $15.65 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.54 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.40 | 2022 | |
| Biogen, INC. | $13.04 | 2021 | |
| Dynavax Technologies Corporation | $8.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Boyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.